TipRanks
Addus Homecare (ADUS)
NASDAQ:ADUS
US Market
ADUS
Addus Homecare
RESEARCH TOOLSreports
Want to see ADUS full AI Analyst Report?

Addus Homecare (ADUS) Stock News & Sentiment

368 Followers
Addus Hold Rating Reiterated as Growth Prospects Offset by Medicaid Uncertainty; $115 Price Target Unchanged
Premium
Ratings
Addus Hold Rating Reiterated as Growth Prospects Offset by Medicaid Uncertainty; $115 Price Target Unchanged
1M ago
ADUS
Addus HomeCare Announces Leadership Transition and Interim COO
Premium
Company Announcements
Addus HomeCare Announces Leadership Transition and Interim COO
2M ago
8K
ADUS
Addus HomeCare Reports Strong Q2 2026 Financial Growth
Premium
Company Announcements
Addus HomeCare Reports Strong Q2 2026 Financial Growth
2M ago
8K
ADUS
Addus HomeCare Corporation (ADUS) Q2 Earnings Cheat Sheet
Premium
Pre-Earnings
Addus HomeCare Corporation (ADUS) Q2 Earnings Cheat Sheet
2M ago
ADUS
Addus Homecare: Buy Rating Reiterated on Steady Volume Momentum, Acquisition Outperformance, and Double-Digit Growth Ambitions
Premium
Ratings
Addus Homecare: Buy Rating Reiterated on Steady Volume Momentum, Acquisition Outperformance, and Double-Digit Growth Ambitions
4M ago
ADUS
Addus HomeCare Delivers Growth, Margin Gains in Q1
Premium
Company Announcements
Addus HomeCare Delivers Growth, Margin Gains in Q1
5M ago
ADUS
Hold Rating Maintained as Solid Momentum Offsets Valuation Concerns; Price Target Trimmed to $110 Amid Medicaid Reform Uncertainty
Premium
Ratings
Hold Rating Maintained as Solid Momentum Offsets Valuation Concerns; Price Target Trimmed to $110 Amid Medicaid Reform Uncertainty
5M ago
ADUS
More ADUS News >

ADUS News on the Web

Can Addus HomeCare (ADUS) Compound Wealth at Scale?
Insider Monkey
Neutral
BTSG Gains More Than 54% YTD: Should You Buy, Hold or Sell?
Zacks
Neutral
Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?
Zacks
Neutral
Analysts Offer Insights on Healthcare Companies: Moleculin Biotech (MBRX), Addus Homecare (ADUS) and Rhythm Pharmaceuticals (RYTM)
TipRanks News
Bullish
ADUS SWOT Analysis: Strong Growth Potential Revealed in 10-Q Filing
GuruFocus News
Bullish
Barclays Remains a Sell on Addus Homecare (ADUS)
TipRanks News
Neutral
Is Addus HomeCare Corp (ADUS) Undervalued After Q2 Earnings Miss? EPS at $1.49 vs. $1. ...
GuruFocus News
Neutral
Addus HomeCare Stock Drops Despite Strong Q2 Beat
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
ADUS
Sector Average
Media Buzz
This Week2 articles
Weekly Average3 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ADUS’s Media Buzz Sentiment?
2 articles about ADUS were published this week. In an average week, 3 articles are published.
    What is ADUS’s weekly average amount of articles?
    In an average week, 3 articles about ADUS are published.
      What is ADUS’s News Sentiment?
      50% of articles about ADUS were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        AMGNAmgen
        GKOSGlaukos
        OVIDOvid Therapeutics
        ABTAbbott Laboratories
        IQVIQVIA Holdings
        Showing the stocks with the most bullish news sentiment over the past week